ERBB2 and breast cancer: These observations suggest that some HER2-overexpressing breast cancer cells become more dependent on β1 signaling as they acquire resistance to L, a potent HER receptor inhibitor, and that blocking this escape pathway can restore inhibition of tumor growth.